Glucose homoeostasis in chronic liver disease. 1986

R Taylor, and D G Johnston, and K G Alberti

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006706 Homeostasis The processes whereby the internal environment of an organism tends to remain balanced and stable. Autoregulation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

R Taylor, and D G Johnston, and K G Alberti
December 1984, Lancet (London, England),
R Taylor, and D G Johnston, and K G Alberti
June 1965, British medical journal,
R Taylor, and D G Johnston, and K G Alberti
July 2012, Nihon rinsho. Japanese journal of clinical medicine,
R Taylor, and D G Johnston, and K G Alberti
November 1984, Lancet (London, England),
R Taylor, and D G Johnston, and K G Alberti
November 1979, Annals of the Royal College of Surgeons of England,
R Taylor, and D G Johnston, and K G Alberti
October 1990, Biochemical Society transactions,
R Taylor, and D G Johnston, and K G Alberti
February 2005, Nihon rinsho. Japanese journal of clinical medicine,
R Taylor, and D G Johnston, and K G Alberti
December 1987, Biochemical Society transactions,
R Taylor, and D G Johnston, and K G Alberti
December 1987, Biochemical Society transactions,
R Taylor, and D G Johnston, and K G Alberti
November 1967, Lancet (London, England),
Copied contents to your clipboard!